Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)-Reference-Cited by-同舟云学术

Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)

Published:2024-03 Issue: Volume:9 Page:100250
ISSN:2772-9060
Container-title:Oral Oncology Reports
language:en
Short-container-title:Oral Oncology Reports

Author:

Senthil Rethinam^ORCID,Raghunandhakumar S.

Publisher

Elsevier BV

Reference6 articles.

1. Polymeric nanomedicines as promising vehicle for solid tumor therapy and targeting;Gupta;Curr Mol Med,2013

2. Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity;Kumar;Sci Rep,2021

3. Nano apatite growth on demineralized bone matrix capped with curcumin and silver nanoparticles: dental implant mechanical stability and optimal cell growth analysis;Senthil;J Oral Biosci,2023

4. Curcumin nanoparticles supported gelatin-collagen scaffold: preparation, characterization, and in-vitro study;Batikan Kavukcu;Toxicol Rep,2021

5. Establishment of an oral squamous cell carcinoma cell line expressing vascular endothelial growth factor a and its two receptors;Araki-Maeda;J Dent Sci,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruthenium (Ru) complex conjugates drugs and targeted tumors by inhibiting oral cancer cells;Oral Oncology Reports;2024-06

2. Inhibitory potential against oral squamous cancer cells demonstrated by amyloid beta peptide (s)/doxorubicin (DOX) conjugates;Oral Oncology Reports;2024-06